{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:55:02Z","timestamp":1793876102955,"version":"4.7.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.eclinm.2024.102860","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T15:54:40Z","timestamp":1727279680000},"page":"102860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Global, regional, and national burden of retinoblastoma in infants and young children: findings from the global burden of disease study 1990\u20132021"],"prefix":"10.1016","volume":"76","author":[{"given":"Jianqi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengsong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guitong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3247-7199","authenticated-orcid":false,"given":"Yehong","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2024.102860_bib1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jamaophthalmol.2013.8001","article-title":"Retinoblastoma incidence patterns in the US surveillance, epidemiology, and end results program","volume":"132","author":"Wong","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.eclinm.2024.102860_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/bjo.2008.139626","article-title":"Retinoblastoma: treatment and survival in great britain 1963 to 2002","volume":"93","author":"MacCarthy","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.eclinm.2024.102860_bib3","doi-asserted-by":"crossref","first-page":"e1128","DOI":"10.1016\/S2214-109X(22)00250-9","article-title":"The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries","volume":"10","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.eclinm.2024.102860_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bjo-2023-324746","article-title":"Retinoblastoma survival and enucleation outcomes in 41 countries from the African continent","author":"Nishath","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.eclinm.2024.102860_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajo.2023.11.004","article-title":"Retinoblastoma outcomes in the americas: a prospective analysis of 491 children with retinoblastoma from 23 American countries","volume":"260","author":"Berry","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.eclinm.2024.102860_bib6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ophtha.2023.10.015","article-title":"Retinoblastoma in Asia: clinical presentation and treatment outcomes in 2112 patients from 33 countries","volume":"131","author":"Kaliki","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.eclinm.2024.102860_bib7","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.ophtha.2016.04.043","article-title":"Correlation of insurance, race, and ethnicity with pathologic risk in a controlled retinoblastoma cohort: a children's oncology group study","volume":"123","author":"Green","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.eclinm.2024.102860_bib8","first-page":"197","article-title":"Genetics and molecular diagnostics in retinoblastoma--an update","volume":"6","author":"Soliman","year":"2017","journal-title":"Asia Pac J Ophthalmol"},{"key":"10.1016\/j.eclinm.2024.102860_bib9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bjophthalmol-2015-307211","article-title":"Incidence and survival of retinoblastoma in Taiwan: a nationwide population-based study 1998-2011","volume":"100","author":"Li","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.eclinm.2024.102860_bib10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ophtha.2020.09.032","article-title":"Global retinoblastoma treatment outcomes: association with national income level","volume":"128","author":"Tomar","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.eclinm.2024.102860_bib11","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/s41388-017-0050-x","article-title":"The management of retinoblastoma","volume":"37","author":"Fabian","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.eclinm.2024.102860_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajo.2017.05.003","article-title":"Long-term visual acuity, strabismus, and nystagmus outcomes following multimodality treatment in group D retinoblastoma eyes","volume":"179","author":"Fabian","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.eclinm.2024.102860_bib13","article-title":"Retinoblastoma","volume":"1","author":"Dimaras","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.eclinm.2024.102860_bib14","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(11)61137-9","article-title":"Retinoblastoma","volume":"379","author":"Dimaras","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2024.102860_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamaoncol.2019.6716","article-title":"Global retinoblastoma presentation and analysis by national income level","volume":"6","author":"Fabian","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eclinm.2024.102860_bib16","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2024.102860_bib17","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2024.102860_bib18","series-title":"Institute for health metrics and evaluation. GBD2021","year":"2024"},{"key":"10.1016\/j.eclinm.2024.102860_bib19","series-title":"Institute for health metrics and evaluation. GBD2021","year":"2020"},{"key":"10.1016\/j.eclinm.2024.102860_bib20","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/bjo.2008.150292","article-title":"The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death","volume":"93","author":"Kivel\u00e4","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.eclinm.2024.102860_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bjo-2023-324086","article-title":"Age-period-cohort analysis of the global burden of visual impairment according to major causes: an analysis of the Global Burden of Disease Study 2019","author":"Chen","year":"2024","journal-title":"Br J Ophthalmol"},{"issue":"397","key":"10.1016\/j.eclinm.2024.102860_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/01621459.1987.10478410","article-title":"Better bootstrap confidence intervals","volume":"82","author":"Efron","year":"1987","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.eclinm.2024.102860_bib23","series-title":"Joinpoint trend analysis software","year":"2023"},{"key":"10.1016\/j.eclinm.2024.102860_bib24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/jgs.18672","article-title":"Temporal trends and projection of blindness and vision loss prevalence in older adults in BRICS countries","volume":"72","author":"Chen","year":"2024","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.eclinm.2024.102860_bib25","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.ophtha.2021.01.024","article-title":"Incidence of retinoblastoma has increased: results from 40 European countries","volume":"128","author":"Stacey","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.eclinm.2024.102860_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000489313","article-title":"The incidence of binocular visual impairment and blindness in children with bilateral retinoblastoma","volume":"5","author":"Stacey","year":"2019","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.eclinm.2024.102860_bib27","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1200\/JCO.18.00141","article-title":"Delayed enucleation with neoadjuvant chemotherapy in advanced intraocular unilateral retinoblastoma: AHOPCA II, a prospective, multi-institutional protocol in Central America","volume":"37","author":"Luna-Fineman","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.eclinm.2024.102860_bib28","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.oret.2020.02.015","article-title":"Impact of systemic chemotherapy and delayed enucleation on survival of children with advanced intraocular retinoblastoma","volume":"4","author":"Zhao","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.eclinm.2024.102860_bib29","doi-asserted-by":"crossref","first-page":"e763","DOI":"10.1542\/peds.2008-0518","article-title":"Retinoblastoma: one world, one vision","volume":"122","author":"Rodriguez-Galindo","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.eclinm.2024.102860_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27959","article-title":"Establishment of a formal program for retinoblastoma: feasibility of clinical coordination across borders and impact on outcome","volume":"66","author":"Al-Haddad","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.eclinm.2024.102860_bib31","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/archophthalmol.2011.292","article-title":"Outcomes of integrating genetics in management of patients with retinoblastoma","volume":"129","author":"Dhar","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.eclinm.2024.102860_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.rbms.2020.03.001","article-title":"Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study","volume":"10","author":"Schofield","year":"2020","journal-title":"Reprod Biomed Soc Online"},{"key":"10.1016\/j.eclinm.2024.102860_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.oret.2017.01.002","article-title":"Foundational elements for collaboration in ophthalmic oncology","volume":"1","author":"Finger","year":"2017","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.eclinm.2024.102860_bib35","doi-asserted-by":"crossref","first-page":"E420","DOI":"10.9778\/cmajo.20190221","article-title":"Canadian Retinoblastoma Research Advisory Board Priority Setting Steering C. The top 10 retinoblastoma research priorities in Canada as determined by patients, clinicians and researchers: a patient-oriented priority-setting partnership","volume":"8","author":"Flegg","year":"2020","journal-title":"CMAJ Open"},{"key":"10.1016\/j.eclinm.2024.102860_bib36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3129\/i09-229","article-title":"Canadian guidelines for retinoblastoma care","volume":"44","author":"Gallie","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.eclinm.2024.102860_bib37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ophtha.2017.09.001","article-title":"Screening children at risk for retinoblastoma: consensus report from the American association of ophthalmic Oncologists and Pathologists","volume":"125","author":"Skalet","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.eclinm.2024.102860_bib38","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ophtha.2020.05.024","article-title":"Recommendations for long-term follow-up of adults with heritable retinoblastoma","volume":"127","author":"Tonorezos","year":"2020","journal-title":"Ophthalmology"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024004395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024004395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:09:41Z","timestamp":1732061381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024004395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":37,"alternative-id":["S2589537024004395"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102860","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global, regional, and national burden of retinoblastoma in infants and young children: findings from the global burden of disease study 1990\u20132021","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102860"}}